The Gujarat Kidney and Super Speciality IPO opened for public subscription on December 22 and saw steady traction on its very first day. By mid-day, the issue was 58% subscribed, reflecting healthy participation from investors, especially from the retail segment.
Early demand was driven largely by retail investors, who came in strong and booked their reserved portion more than twice, setting the tone for the opening session.
Market Performance: Day 1 Subscription Status
As of 12:15 pm, the IPO had received bids for over 76 lakh shares, against a total offer size of 1.32 crore shares, according to NSE data.
- Overall subscription: 58%
- Retail investors: 241% (over 2x subscribed)
- Non-Institutional Investors (NII): 71%
- Qualified Institutional Buyers (QIB): No major bids yet
The numbers show clear interest from retail and non-institutional participants on Day 1 of the Gujarat Kidney and Super Speciality IPO.
Main News: IPO Structure and Timeline
Gujarat Kidney and Super Speciality aims to raise ₹250.80 crore from the primary markets. The IPO is a pure fresh issue of up to 2.20 crore equity shares, with no offer for sale (OFS) component.
This structure means the entire IPO proceeds will go directly to the company, supporting its expansion and growth plans.
Key IPO details:
- Price band: ₹108–₹114 per share
- Issue opens: December 22
- Issue closes: December 24
- Allotment date: December 29
- Listing date: December 30
- Stock exchanges: BSE and NSE
Retail investors need to bid for at least 128 shares, which translates to an investment of ₹14,592 at the upper price band.
Anchor Book: Strong Pre-IPO Participation
Ahead of the public issue, the company raised over ₹100 crore from anchor investors on December 19.
A total of 87.73 lakh equity shares were allotted to 10 anchor investors at the upper price band.
- Craft Emerging Market Fund (via Citadel Capital Fund and Elite Capital Fund):
- 39.47 lakh shares
- ₹45 crore investment
- Khandelwal Finance:
- 13.16 lakh shares
- ₹15 crore
- Venus Investments:
- 8.77 lakh shares
- ₹10 crore
The anchor participation added early visibility to the Gujarat Kidney and Super Speciality IPO ahead of its public opening.
How the IPO Proceeds Will Be Used?
Gujarat Kidney and Super Speciality currently operates seven multi-speciality hospitals and four pharmacies across Gujarat, with a combined capacity of 490 beds.
The company has laid out a clear plan for deploying the fresh issue proceeds:
- ₹77 crore: Acquisition of Parekhs Hospital, Ahmedabad
- ₹12.4 crore: Part payment for Ashwini Medical Centre
- ₹10.78 crore: Additional stake in subsidiary Harmony Medicare
- ₹30.09 crore: Setting up a new hospital in Vadodara
- ₹6.8 crore: Purchase of robotics equipment
- ₹1.2 crore: Partial debt repayment
- Remaining funds: Inorganic growth and general corporate purposes
Company Details
Gujarat Kidney and Super Speciality operates in the healthcare space, focusing on multi-speciality hospital services. Its current network across Gujarat reflects a growing presence in the regional healthcare market.
The IPO proceeds are structured to support both capacity expansion and strategic acquisitions, while also strengthening subsidiary operations.
Summary
The Gujarat Kidney and Super Speciality IPO saw a steady start on Day 1, with 58% subscription led by strong retail participation.
- Retail portion subscribed over 2x
- NII portion subscribed 71%
- IPO size: ₹250.80 crore, entirely fresh issue
- Anchor investors infused ₹100+ crore ahead of launch
- Funds earmarked for hospital acquisitions, expansion, and equipment
As the IPO remains open until December 24, investor interest will continue to be tracked closely over the remaining subscription days.
Source: Moneycontrol
Easy & quick
Leave A Comment?